DOPATREE
COMPANIES-ALL (COMPANY, CLIENTS, SPONSORS, SMALL, MID-SIZE, LARGE PHARMA, BIG PHARMA, BIOPHARMA, EMERGING COMPANIES, STARTUPS, START-UPS, SPIN-OFFS, SUBSIDIARIES, SUBSIDIARY, BIOTECHNOLOGY, EMERGING)
COMPANIES / LISTINGS-N
NOVARTIS
NOVARTIS / PRODUCTS / APPROVED
PLUVICTO™ (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN)
PLUVICTO / WARNINGS AND PRECAUTIONS
EMBRYOFETAL TOXICITY (EMBRYONIC DEVELOPMENT, STUDIES, DEVELOPMENTAL TOXICITY, EMBRYO-FETAL, REPRODUCTIVE TOXICITY, TERATOGENICITY, RISK OF DRUG EXPOSURE DURING PREGNANCY)
EMBRYOFETAL TOXICITY / MITIGATIONS

PREGNANCY PREVENTION PROGRAMME (PROGRAMS, PPP)

Parents